similar between the two groups. With respect to specific nonvascular surgery specialties, the rate of 30-day stroke or death was higher in endarterectomy patients treated by neurosurgeons (4.1%; adjusted OR, 1.27; 95% CI, 1.00-1.61) and cardiac surgeons (4.4%; adjusted OR, 1.54; 95% CI, 1.04-2.30) compared with vascular surgeons (2.9%). Patients who underwent carotid artery stenting by radiologists vs neurosurgeons experienced 30-day stroke or death at similar rates (8.0% vs 7.9%, respectively; adjusted OR, 1.07; 95% CI, 0.66-1.74; P ¼ .79).
Conclusions:
The risk for periprocedural stroke or death was significantly higher among carotid endarterectomy patients treated by nonvascular surgeons (neurosurgeons and cardiac surgeons) compared with vascular surgeons. Operator specialty did not seem to have a significant effect on periprocedural outcomes among patients who underwent carotid artery stenting. These results can have implications for physician referral practices and local policies. (J Vasc Surg 2018;67: 478-89.) Although carotid endarterectomy is considered the gold standard treatment for stroke prevention in patients with significant carotid artery atherosclerosis, carotid artery stenting has recently gained popularity as an alternative to surgical endarterectomy. 1 Our previous work
showed that the clinical use of carotid artery stenting has increased by 72% in Ontario, Canada, between 2002 and 2014, whereas carotid endarterectomy has decreased by 36%. 2 This is largely due to findings from large, multicenter, randomized, controlled trials that indicate carotid stenting may be a safe and efficacious alternative to endarterectomy. [3] [4] [5] [6] More recently, several studies have focused on identifying patient-, hospital-, or operator-level factors that may influence outcomes after different carotid revascularization strategies. For example, high-quality data from randomized trials indicate that older patients ($70 years old) who undergo carotid artery stenting experience stroke or death at a higher rate compared with endarterectomy. 7, 8 Furthermore, several authors have reported an inverse relationship between hospital or operator volume and periprocedural events, with higher event rates among endarterectomy and stenting patients treated at low-volume centers or by lowvolume operators. [9] [10] [11] [12] However, few studies have examined the effect of operator specialty on outcomes after carotid revascularization. In Ontario, several different operator specialties perform carotid endarterectomy and stenting, and there have been significant changes in the use of these procedures based on operator specialty. 2 The influence of operator specialty on outcomes after carotid endarterectomy and stenting, however, is not clear. Therefore, the objective of our study was to examine the impact of operator specialty on the risk of periprocedural events after carotid artery revascularization.
METHODS
Study design and setting. We designed a retrospective, population-based, observational cohort study using linked administrative claims databases in Ontario, Canada from April 1, 2002 , to March 31, 2015 . These databases, listed in the Supplementary Methods (online only), are linked using a unique patient identifier; they capture all healthcare interactions of the 13.6 million residents of Ontario; they are of high quality with validated coding algorithms to measure cardiovascular health and healthcare services 13 ; they are routinely used for population-based epidemiologic studies of patients with vascular diseases 2, 14, 15 ; and they are stored at the Institute for Clinical Evaluative Sciences, which is a prescribed entity under the Personal Health Information Privacy Act that houses and allows for usage of patient health information for research purposes without patient consent. The research ethics review boards at St. Michael's Hospital and Sunnybrook Health Science Centre approved this study. The first and last authors vouch for the accuracy of the analysis.
Patient population. We identified all patients aged $40 years who underwent carotid endarterectomy or carotid artery stenting between April 1, 2002 , and March 1, 2015, using Canadian Classification of Health Intervention codes 1JE57Lx (endarterectomy) and 1JE50x (stenting). These codes have been validated to accurately identify patients treated by carotid endarterectomy (positive predictive value, 99%; sensitivity, 90%) and carotid artery stenting (positive predictive value, 87%; sensitivity, 93%) in our databases. 16 Patients who had both carotid revascularization procedures during the same admission, and those who had combined coronary and carotid artery revascularization were excluded. We also excluded patients who had missing operator data (such as operator specialty or identification number), and those who were treated by specialists that performed <2% of carotid revascularization procedures during the study period. For example, vascular surgeons performed <1% of carotid artery stenting in Ontario during the study period; therefore, vascular surgery-treated stenting patients were excluded from the analysis.
Covariates. We first established individual operator specialties using the Institute for Clinical Evaluative Sciences Physicians Database that records data on Ontario physicians. We then measured several baseline patient-, procedure-, institution-, and operator-specific variables that may confound the association between operator specialty and outcomes after carotid revascularization. Details of these covariates are provided in the Supplementary Methods (online only).
Outcomes. We examined the 30-day rates of any stroke, death and composite of any stroke or death after the carotid procedure. We used validated diagnostic codes based on the International Classification of Diseases, Tenth Revision to define stroke (I60.x, I61.x, I62.x, I63.x, I64.x, H34.1). Stroke coding has shown to be 92% accurate in our administrative databases. 17 Analytical approach. We first stratified our cohort by carotid revascularization procedure, and then stratified further on the basis of operator specialty. For endarterectomy, we compared baseline characteristics and outcomes between vascular surgeons and nonvascular surgeons. For carotid artery stenting, we compared baseline characteristics and outcomes between radiologists and neurosurgeons. We used standardized differences to compare baseline characteristics among our cohorts because standardized differences are not as sensitive to sample size as traditional significance testing; therefore, they provide a sense of relative magnitude of differences. 18 A standardized difference of >0.1 indicates significant difference. 19 To compare outcomes by operator specialty, we performed multilevel multivariable logistic regression analysis using generalized estimating models. We first used baseline variables listed in the Supplementary Methods (online only) to build our models, and then applied a forward-selection variable reduction approach with a P value for inclusion of <.05 in our final models to calculate adjusted odds ratios (ORs); these models also accounted for within-operator clustering. We also examined the rate of 30-day stroke or death in several predefined subgroups: age (<70 and $70 years), sex, carotid artery symptoms, year of procedure, hospital type, and annual hospital and operator volumes. In addition, we examined outcomes of endarterectomy patients treated by different nonvascular surgery specialists (neurosurgeons, general surgeons, and cardiac surgeons) compared with vascular surgeons. Finally, we performed confirmatory analyses using propensity score methods to ensure results our results were robust and reproducible. Details of the propensity score methods are provided in the Supplementary Methods (online only). All statistical analyses were conducted using SAS Enterprise Guide, version 7.1 (SAS Institute, Cary, North Carolina). All P values are two-sided, and P < .05 was considered statistically significant.
RESULTS
Study population. A total of 16,544 patients who had undergone carotid artery revascularization met the inclusion criteria for this study (14,301 endarterectomy and 2243 stenting; Fig 1) . Vascular surgeons performed the majority (55.7%) of carotid endarterectomy procedures, followed by neurosurgeons (21.0%), general surgeons (15.3%), and cardiac surgeons (7.9%; Fig 2) . Radiologists (82.5%) and neurosurgeons (17.5%) performed carotid artery stenting.
With respect to baseline characteristics, there were notable differences between vascular surgery and nonvascular surgery-treated endarterectomy patients (Table I) . Vascular surgery patients were more likely to have a rural residence and have asymptomatic carotid stenosis (62% vs 54% for nonvascular surgery). Nonvascular surgeons were more likely to perform endarterectomy earlier in the study period between 2002 and 2006 (49% vs 32% for vascular surgeons), whereas vascular surgeons were more likely to perform endarterectomy later in the study period, between 2011 and 2015 (37% vs 21% for nonvascular surgeons). Vascular surgeons also performed endarterectomy more commonly at academic hospitals, stroke centers, and at medium-or high-volume hospitals. Furthermore, vascular surgeons tended to be high-volume operators (37% vs 28% for nonvascular surgeons), whereas nonvascular surgeons were more likely to be low-volume operators (40% vs 31% for vascular surgeons). Baseline characteristics of the matched endarterectomy cohort were similar (Supplementary Table II In the propensity score-matched analysis, a total of 3197 nonvascular surgery-treated patients were successfully matched with 3197 vascular surgery-treated patients. The risk of 30-day stroke or death was significantly higher among nonvascular surgeons (4.4%) compared with vascular surgeons (3.2%) in the matched cohort (adjusted OR, 1.35; 95% CI, 1.01-1.80), which was consistent with our findings from multivariable analyses.
Stenting outcomes. Patients who underwent carotid artery stenting by radiologists vs neurosurgeons experienced 30-day stroke or death at similar rates (8.0% vs 7.9%, respectively; adjusted OR, 1.07; 95% CI, 0.66-1.74; P ¼ .79). Moreover, there were no differences in the individual rates of 30-day stroke or 30-day death. The 30-day outcomes of stenting patients treated by different types of operators are presented in Fig 4. With respect to the propensity score-matched analysis, a total of 306 radiology-stented patients were matched with 306 neurosurgery-stented patients. The risk of 30-day stroke or death was also similar between radiologists (6.9%) and neurosurgeons (8.5%) in the matched cohort (adjusted OR, 1.27; 95% CI, 0.59-2.72).
Subgroup analyses. Significant differences were found with respect to stroke or death rates after endarterectomy in various subgroups (Table II) . Notably, a higher risk was observed among asymptomatic patients treated by nonvascular surgeons (3.3% vs 2.3% for vascular surgeons; adjusted OR, 1.42; 95% CI, 1.06-1.91; Fig 5) . The risk of stroke or death was similar among symptomatic patients treated by vascular surgeons (4.0%) and nonvascular surgeons (4.8%; adjusted OR, 1.23; 95% CI, 0.93-1.63). We also found that high-volume vascular surgeons had the lowest rate of stroke or death after endarterectomy (2.5%)dand this rate was considerably lower that of high-volume nonvascular surgeons (4.5%; adjusted OR, 1.96; 95% CI, 1.42-2.70; Fig 6) .
Age, sex, carotid artery symptoms (Fig 5) , hospital type, and annual hospital and operator volume (Fig 6) did not seem to influence the outcomes of carotid artery stenting patients treated by radiologists vs neurosurgeons (Table II) . However, we did find the risk of stroke or death was higher among patients treated by neurosurgeons between 2002 and 2006 (13.9% vs 9.1% for radiologists; adjusted OR, 1.74; 95% CI, 1.20-2.53); the rates of stroke or death were similar in subsequent study periods (2007-2010 and 2011-2015) . The rates of 30-day stroke after stenting and endarterectomy by subgroups are presented in Supplementary Table III (online only) .
Cause of death. With respect to causes of 30-day death, we found that >80% of endarterectomy and stenting patients died of cardiovascular-related causes, regardless of operator specialty (Supplementary Table IV , online only).
DISCUSSION
In this population-level study, we found that endarterectomy patients treated by nonvascular surgeons had an increased risk of 30-day stroke or death compared with those treated by vascular surgeons. This difference was driven by an increased risk of stroke among patients treated by nonvascular surgeons, whereas the risk of death was similar between the two groups. Patients treated by neurosurgeons and cardiac surgeons seemed to be at the greatest risk of events compared with vascular surgeons. General surgeons also had an increased risk of stroke or death relative to vascular surgeons; however, this did not attain statistical significance, perhaps owing to lack of statistical power. Furthermore, some of these general surgeons likely also have formal training in vascular surgery, but used their general surgery certification for the purposes of billing. With respect to carotid artery stenting, we found rates of stroke or death to be similar between radiologists and neurosurgeons, although neurosurgery-treated patients experienced worse outcomes before 2007.
Few other authors have examined the effect of operator specialty on outcomes of carotid revascularization procedures. Enomoto Other older studies conducted in cohorts of patients who underwent endarterectomy in the 1990s have provided conflicting evidence on the effect of operator specialty on outcomes. [22] [23] [24] [25] Several factors may help to explain the differences seen in outcomes seen in our study among endarterectomy patients treated by different operators. Nonvascular surgeons are performing fewer endarterectomy in Ontario, with a 64%, 36%, and nearly 100% decrease in endarterectomy performed by neurosurgeons, general surgeons, and cardiac surgeons between 2002 and 2014, respectively. 2 Vascular surgeons, in contrast, performed approximately 10% more endarterectomy during this period, and they accounted for approximately 70% of all endarterectomy procedures performed in 2014. Therefore, the superior outcomes observed among vascular surgerytreated patients may be related to greater operator expertise and familiarity with the endarterectomy procedure. This argument is supported by our observation that, even among high-volume operators, vascular surgeons had a lower event rate after endarterectomy (2.5%) compared with nonvascular surgeons (4.5%). Furthermore, this trend was also observed in the Carotid Revascularization Endarterectomy vs Stenting Trial (CREST), in which vascular surgeons performed the majority (65%) of the 1184 endarterectomy procedures, and the periprocedural stroke or death rate was nearly 70% lower among vascular surgery vs nonvascular surgery-treated patients (1.2% vs 3.8%, respectively; hazard ratio, 0.32; 95% CI, 0.14-0.72; P ¼ .006). 26 This vascular surgeons had a lower risk of stroke or death compared with other specialists, which was largely related to the higher use of eversion endarterectomy, protamine, or shunts by vascular surgeons. Unfortunately, we were not able to capture these operative factors in our study owing to limitations in our administrative datasets.
With respect to carotid artery stenting, contemporary population-level 27, 28 and registry-based studies 29, 30 from the United States suggest that different operator specialties have similar outcomes, and institutional and provider experience appears to be a stronger predictor of outcomes after carotid stenting. Furthermore, a subanalysis of the CREST trial showed no differences in the rates of periprocedural stroke or death among patients who underwent stenting by vascular surgeons vs other specialists (3.8% vs 4.5%, respectively). 26 Unlike the United States, however, where cardiologists (52%) and vascular surgeons (17%) perform the majority of carotid stenting procedures, 9 radiologists and neurosurgeons are the primary physicians delivering this intervention 2 Interestingly, we found that, although carotid stenting is relatively centralized in Ontario (>85% of procedures by radiologists and 100% by neurosurgeons were performed in specialized stroke centers), the overall volumes of individual hospitals and operators were relatively low. For example, 40% of radiologists and 48% of neurosurgeons performed carotid stenting in lowvolume centers (<20 procedures per years); and 29% of radiologists and 62% of neurosurgeons were considered low-volume operators, as they performed <3.5 carotid stenting procedures per year. This may help to explain the overall high event rates seen in patients treated by carotid stenting relative to endarterectomy. The American Heart Association (AHA) practice guidelines recommend that carotid revascularization should be considered in symptomatic patients who have an anticipated periprocedural stroke or death rate of <6%, or in selected asymptomatic patients who have a periprocedural risk of <3%. 31, 32 In the current study, the rates of stroke or death were 7.8% and 8.1% among symptomatic patients treated by radiologists and neurosurgeons, respectively; and 8.2% and 7.7% among asymptomatic patients, respectivelydthese were well above the AHA recommended thresholds. In contrast, stroke or death rates among symptomatic endarterectomy patients were within the 6% AHA threshold, regardless of operator specialty (4.0% for vascular surgeons and 4.8% for nonvascular surgeons), and within the 3% threshold for asymptomatic patients treated by vascular surgeons (2.3%). The rate among asymptomatic endarterectomy patients treated by nonvascular surgeons (3.3%) was modestly higher than the <3% AHA threshold. Furthermore, these higher rates of periprocedural stroke or death with stenting compared with endarterectomy have also been observed in several other registry-based studies, 33 including a recent long-term (13-year) analysis of 15,525 Ontario individuals that showed stenting is associated with an early and sustained 55% increased risk for major events compared with endarterectomy. 34 To achieve low event rates after carotid stenting equivalent to those seen in clinical trials, rigorous operator training and experience is required, along with meticulous patient selection after considering several patient, disease, and anatomic factors. 1 Nonetheless, whether patients receive endarterectomy or stenting in Canada is generally guided by operator and institutional For subgroups with low (<20) outcome events in one of the comparison groups, ORs are based on simple multilevel logistic regression models.
preference and experiencedthis is in contrast with other health systems (such as Medicare in the United States), where reimbursement policies may also influence selection of carotid revascularization strategy.
Our study results should be interpreted in light of some limitations. First, inaccurate coding in our databases could have biased our results; however, we used diagnostic and procedure codes that have been previously validated to conduct our analyses. 16 Second, owing to limitations of our datasets, we were not able to capture intraoperative factors that may confound the relationship between operator specialty and carotid revascularization outcomes, such as conventional vs eversion endarterectomy, use of shunts or patches during endarterectomy, or embolic protection device usage during stenting. Third, the actual number of patients who had symptomatic carotid artery stenosis may not be precise, because we were not able to decipher whether patients had a prior ipsilateral or contralateral neurologic event, nor were we able to capture neurologic events in the community that did not result in a hospitalization or emergency department visit. Therefore, the actual proportion of asymptomatic patients may have been overestimated in our study. Certainly, lower rates of periprocedural stroke or death after endarterectomy in asymptomatic patients have been reported in contemporary clinical trials (1.2%-1.7%) 4 ,6 compared with our study (2.3%-3.3%). Therefore, the possibility exists that some symptomatic patients may have been inaccurately identified as asymptomatic in our study, thus inflating the overall event rate among asymptomatic patients. However, this would have affected all patients equally regardless of treating operator specialty. Nonetheless, the subgroup analyses of patients by symptom status should be interpreted in the context of this limitation. Fourth, we were not able to further characterize the type of periprocedural stroke. Finally, our results were limited to 30-day follow-up; long-term differences in outcomes are not known.
CONCLUSIONS
In the current population-level study, we found that endarterectomy patients treated by vascular surgeons had a lower rate of periprocedural stroke or death compared with those treated by nonvascular surgeons. Furthermore, in the context of decreasing rates of endarterectomy performed by nonvascular surgeons over the last decade, our results indicate that vascular surgeons seem to have emerged as the primary specialists to deliver this intervention with the lowest event ratesdthis finding can have implications for physician referral practices and local policies. Further research is necessary to identify operative factors that may contribute to higher event rates among endarterectomy patients treated by nonvascular surgeons. Operator specialty did not seem to have a significant effect on periprocedural outcomes among patients who underwent carotid artery stenting.
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Supplementary Methods
Sources of data. The following administrative databases were used to conduct this study: the Canadian Institute for Health Information Discharge Abstract Database (records all hospitalizations in Ontario acute care hospitals); the Ontario Health Insurance Plan Claims Database (records data on physician and health care provider billing claims); the Registered Persons Database (records demographic and vital statistics data); the National Ambulatory Care Reporting System (records data on ambulatory and emergency department visits); and the Institute for Clinical Evaluative Sciences Physicians Database (records information on physicians practicing in Ontario).
Covariates. With respect to patient demographics, we measured age, sex, residence (rural vs urban), and socioeconomic status (approximated by linking the patient's home postal code to Statistics Canada population census data to establish neighborhood income quintiles). 1 We measured overall patient comorbidity burden using the Carlson Comorbidity Index within 1 year before the index carotid proceduredthis comorbidity index has been validated to predict the risk of death from comorbid conditions in patients with vascular disease. 2 We also measured individual medical comorbidities and prior coronary and peripheral revascularization procedures #5 years before the index procedure date using validated coding algorithms in our databases (Supplementary Table I , online only). Prior carotid endarterectomy was captured #10 years before the index date. We defined symptomatic carotid artery stenosis as a prior hospitalization or emergency department visit within the last 6 months with ischemic stroke or transient ischemic attack. We also estimated patient health services use by establishing the numbers of hospitalizations and emergency department visits in the past 3 years, and outpatient physician visits in the past year before the index date. See Supplementary Table I (online  only) for coding definitions of all comorbid conditions and their validity in our databases. Procedure-specific factors measured included year of procedure (2002-2006, 2007-2010, or 2011-2015) and urgent vs elective admission. We also measured the following institution-specific variables: type of hospital (academic vs community; stroke center vs nonstroke center), geographic region, and annual hospital volume of carotid revascularization procedures. We established annual hospital volumes of endarterectomy and stenting by first establishing the total number of procedures performed at each hospital during the study period. We then annualized this number by dividing it by study duration in years. Finally, we stratified annual hospital volumes for endarterectomy and stenting into three categories (low, medium, high) based on tertiles. We also used the same approach to established annual operator volumes of carotid procedures.
Variables used in multivariable analyses. To build a list of variables to enter in our multivariable analyses, we first assessed for multicollinearly among all our baseline covariates. We excluded variables that were highly collinear (income quintile 5 and stroke center) as indicated by a variance inflation factor of >5, and entered the following variables in our multivariable analyses: age, sex, rural residence, income quintile 1, income quintile 2, income quintile 3, income quintile 4, Carlson Comorbidity Index, mean outpatient physician visits in past year, mean emergency department visits in past 3 years, mean hospital admissions in past 3 years, symptomatic carotid stenosis, coronary artery disease, acute myocardial infarction, congestive heart failure, peripheral arterial disease, diabetes mellitus, hypertension, chronic obstructive disease, chronic kidney disease, prior carotid endarterectomy, coronary revascularization, peripheral arterial revascularization, year of procedure, urgent admission, academic hospital, geographic region, annual hospital volume, and annual operator volume.
Propensity score methods. To perform confirmatory propensity score-matched analyses, we first calculated propensity scores for the endarterectomy and stenting cohorts by building logistic regression models that accounted for all baseline covariates (age, sex, rural residence, income quintile, Carlson Comorbidity Index, mean outpatient physician visits in past year, mean emergency department visits in past 3 years, mean hospital admissions in past 3 years, symptomatic carotid stenosis, coronary artery disease, acute myocardial infarction, congestive heart failure, peripheral arterial disease, diabetes mellitus, hypertension, chronic obstructive disease, chronic kidney disease, prior carotid endarterectomy, coronary revascularization, peripheral arterial revascularization, year of procedure, urgent admission, academic hospital, geographic region, annual hospital volume, and annual operator volume). We then matched endarterectomy patients treated by nonvascular surgeons to those treated by vascular surgeons in a 1:1 manner on the basis of this propensity score and the following additional important confounders: year of procedure, urgent admission, academic hospital, annual hospital volume, annual operator volume, age, and history of peripheral arterial disease. Stenting patients treated by neurosurgeons were matched in a 1:1 ratio to those treated by radiologists on the basis of the propensity score, year of procedure, urgent admission, academic hospital, annual hospital volume, annual operator volume, Carlson Comorbidity Index, and history of peripheral arterial revascularization.
Standardized differences were then calculated after matching to ensure all of the baseline covariates were equally distributed between the cohorts; a standardized difference of >0.1 was considered significant. In the endarterectomy cohort, all baseline variables were equally distributed after matching, except rural residence and geographic region. In the stenting cohort, only hypertension and geographic region remained unequally distributed after matching. Finally, we built multilevel logistic regression models that accounted for clustering of individual operators to compare the risk of 30-day stroke or death in the matched endarterectomy and stenting cohorts. We also adjusted for important covariates that remained unbalanced after matching in these models (rural residence was added in the model for endarterectomy and hypertension was added in the model for stenting). a Causes of death data were missing for 7 patients that died after endarterectomy. Causes of death data were missing for 10 patients that died after stenting. Values are presented as number (%). Cells containing n # 5 observations are suppressed.
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